J-GLOBAL ID:200901056781420119   Update date: May. 09, 2020

Yamashita Tomoya

ヤマシタ トモヤ | Yamashita Tomoya
Affiliation and department:
Job title: Associate Professor
Research field  (3): Internal medicine - General ,  Bacteriology ,  Cardiology
Research keywords  (2): Vascular biology ,  Atherosclerosis
Research theme for competitive and other funds  (1):
  • 2018 - 2022 Unraveling the anti-inflammatory mechanisms of human 2 Bacteroides species and their application for treating chronic inflammatory diseases.
Papers (59):
  • Masato Ogawa, Naofumi Yoshida, Seimi Satomi-Kobayashi, Yasunori Tsuboi, Kodai Komaki, Kumiko Wakida, Yasuko Gotake, Takeshi Inoue, Hiroshi Tanaka, Tomoya Yamashita, Yoshitada Sakai, Kazuhiro P Izawa, Michiko Takahashi, Wataru Ogawa, Ken-Ichi Hirata. Efficacy of preoperative amino acid supplements on postoperative physical function and complications in open heart surgery patients: A study protocol for a randomized controlled trial. Journal of cardiology. 2019. 74. 4. 360-365
  • Amin HZ, Sasaki N, Yamashita T, Mizoguchi T, Hayashi T, Emoto T, Matsumoto T, Yoshida N, Tabata T, Horibe S, Kawauchi S, Rikitake Y, Hirata KI. CTLA-4 Protects against Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice. Scientific reports. 2019. 9. 1. 8065
  • Hayashi T, Yamashita Tomoya, Watanabe H, Kami K, Yoshida N, Tabata T, Emoto T, Sasaki N, Mizoguchi T, Irino Yasuhiro, Toh Ryuji, Shinohara M, Okada Y, Ogawa Wataru, Yamada T, Hirata Ken-ichi. Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure. Circ J. 2018. 83. 1. 182-192
  • Yoshida N, Sasaki K, Sasaki D, Yamashita Tomoya, Fukuda H, Hayashi T, Tabata T, Osawa R, Hirata Ken-ichi, Kondo A. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease. J Atheroscler Thromb. 2018
  • Yoshida N, Emoto T, Yamashita Tomoya, Watanabe H, Hayashi T, Tabata T, Hoshi Namiko, Hatano N, Ozawa G, Sasaki N, Mizoguchi T, Amin HZ, Hirota Yushi, Ogawa Wataru, Yamada T, Hirata Ken-ichi. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation. 2018. 138. 22. 2486-2498
MISC (95):
  • Tomoya Yamashita, Naofumi Yoshida, Tomohiro Hayashi, Tokiko Tabata, Takuo Emoto, Ken-ichi Hirata. Gut microbiota and Cardiovascular diseases. PROGRESS IN MEDICINE. 2020. 40. 3. 31-37
  • Tomoya Yamashita. Diabetes mellitus and gut microbiota. 2020. 17. 1. 31-33
  • Cardiovascular diseases and gut microbiota. 2019. 50. 9. 504-512
  • Progress in cardiology 2019 Advance in ischemic heart disease and atherosclerosis. 2019. 28. 81-84
  • Atherosclerosis and gut microbiota. 2019. 37. 4. 388-394
Books (9):
  • Current Therapy in Cardiovascular Diseases
  • Atherosclerosis in clinics
  • Gut microbiota ~Another organ for controlling human health and disease~
  • Molecular Cardiology for developing new clinical medicine
  • Gut and oral microbiota in systemic diseases
    シーエムシー出版 2015
Lectures and oral presentations  (164):
  • Gut microbiome and atherosclerosis
  • 糖尿病薬の腸内細菌への影響と腸内細菌叢から見た動脈硬化予防
    (第53回糖尿病のの進歩 2019)
  • 冠動脈疾患患者大腸フローラモデルによる候補投与物の調査
    (日本農芸化学会2019年度大会 2019)
  • The Correlation between Circulating Intermediate CD14++CD16+Monocytes and Atrial Electrical Remodeling in Atrial Fibrillation Patients
    (第83回日本循環器学会学術集会 2019)
  • Gut microbiome, novel therapeutic targets for preventing atherosclerotic cardiovascular diseases
    (第83回日本循環器学会学術集会 2019)
Awards (2):
  • 2016/07 - 日本動脈硬化学会 五島雄一郎賞 Intestinal Immunity and Gut Microbiota in Atherogenesis.
  • 2011/04 - American Heart Association 2011 Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins
Association Membership(s) (3):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page